Boshi Huang

2.2k citations

70 papers · 1.8k · h-index 24

Impact in

Virology top 1%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment

Papers in

Infectious Diseases 37
- HIV/AIDS drug development and treatment 37
Virology 30
- HIV Research and Treatment 30

Co-authors: Xinyong Liu (47 shared papers)Peng Zhan (40 shared papers)Dongwei Kang (33 shared papers)Erik De Clercq (32 shared papers)Christophe Pannecouque (31 shared papers)Yan Zhang (16 shared papers)Dirk Daelemans (19 shared papers)Xueshun Wang (3 shared papers)
Journals: European Journal of Medicinal Chemistry (14 papers)Journal of Medicinal Chemistry (8 papers)Drug Discovery Today (4 papers)Expert Opinion on Therapeutic Patents (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)
Partner nations: China Belgium United States

In The Last Decade

Boshi Huang

70 papers receiving 1.7k citations

Peers

Countries citing papers authored by Boshi Huang

Since Specialization

Citations

This map shows the geographic impact of Boshi Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boshi Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boshi Huang more than expected).

Fields of papers citing papers by Boshi Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boshi Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boshi Huang. The network helps show where Boshi Huang may publish in the future.

Co-authors

The 25 scholars most cited alongside Boshi Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Boshi Huang Line = papers co-authored together Boshi Huang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries Drug Discovery Today ·Xueshun Wang, Boshi Huang, Xinyong Liu, Peng Zhan	2015	153
2	Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles Journal of Medicinal Chemistry ·Dongwei Kang, Zengjun Fang, Zhenyu Li, Boshi Huang, Heng Zhang, Xueyi Lu, Haoran Xu, Zhongxia Zhou, Xiao Ding, Dirk Daelemans, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2016	120
3	Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors Life Sciences ·T.B. Ng, Boshi Huang, Wing‐Ping Fong, H.W. Yeung	1997	110
4	Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants Journal of Medicinal Chemistry ·Dongwei Kang, Zengjun Fang, Boshi Huang, Xueyi Lu, Heng Zhang, Haoran Xu, Zhipeng Huo, Zhongxia Zhou, Yu Zhao, Qing Meng, Gaochan Wu, Xiao Ding, Ye Tian, Dirk Daelemans, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2017	85
5	Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches European Journal of Medicinal Chemistry ·Boshi Huang, Cuicui Li, Wen‐Ming Chen, Tao Liu, Mingyan Yu, Lu Fu, Yueyue Sun, Huiqing Liu, Erik De Clercq, Christophe Pannecouque, Jan Balzarini, Peng Zhan, Xinyong Liu	2015	83
6	Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus European Journal of Medicinal Chemistry ·Ye Tian, Zhaoqiang Liu, Jinghan Liu, Boshi Huang, Dongwei Kang, H. Zhang, Erik De Clercq, Dirk Daelemans, Christophe Pannecouque, Kuo‐Hsiung Lee, Chin‐Ho Chen, Peng Zhan, Xinyong Liu	2018	81
7	Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles Journal of Medicinal Chemistry ·Boshi Huang, Wen‐Ming Chen, Tong Zhao, Zhenyu Li, Xiangyi Jiang, Tiziana Ginex, David Vı́lchez, F. Javier Luque, Dongwei Kang, Ping Gao, (unknown), Ye Tian, Dirk Daelemans, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2019	72
8	Design, synthesis and biological evaluation of tacrine-1,2,3-triazole derivatives as potent cholinesterase inhibitors MedChemComm ·Gaochan Wu, Yun Gao, Dongwei Kang, Boshi Huang, Zhipeng Huo, Huiqing Liu, Vasanthanathan Poongavanam, Peng Zhan, Xinyong Liu	2017	63
9	Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives Journal of Medicinal Chemistry ·Han Ju, Jian Zhang, Boshi Huang, Dongwei Kang, Bing Huang, Xinyong Liu, Peng Zhan	2017	60
10	Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs Acta Pharmaceutica Sinica B ·Dongwei Kang, Da Feng, Tiziana Ginex, Jinmi Zou, Fenju Wei, Tong Zhao, Boshi Huang, Yanying Sun, Samuel Desta, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2019	45
11	Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: Design, synthesis and biological evaluation of novel imidazo[1,2-a]pyrazines European Journal of Medicinal Chemistry ·Boshi Huang, Xin Liang, Cuicui Li, Wen‐Ming Chen, Tao Liu, Xiao Li, Yueyue Sun, Lu Fu, Huiqing Liu, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2015	43
12	Teaching an old dog new tricks: Drug discovery by repositioning natural products and their derivatives Drug Discovery Today ·Boshi Huang, Yan Zhang	2022	43
13	First discovery of novel 3-hydroxy-quinazoline-2,4(1H,3H)-diones as specific anti-vaccinia and adenovirus agents via ‘privileged scaffold’ refining approach Bioorganic & Medicinal Chemistry Letters ·Dongwei Kang, Heng Zhang, Zhongxia Zhou, Boshi Huang, Lieve Naesens, Peng Zhan, Xinyong Liu	2016	39
14	Design of bivalent ligands targeting putative GPCR dimers Drug Discovery Today ·Boshi Huang, Celsey M. St. Onge, Hongguang Ma, Yan Zhang	2020	38
15	Medicinal Chemistry Insights in the Discovery of Novel LSD1 Inhibitors Epigenomics ·Xueshun Wang, Boshi Huang, Takayoshi Suzuki, Xinyong Liu, Peng Zhan	2015	37
16	Design, synthesis, and biological evaluation of piperidinyl‐substituted [1,2,4]triazolo[1,5‐a]pyrimidine derivatives as potential anti‐HIV‐1 agents with reduced cytotoxicity Chemical Biology & Drug Design ·Boshi Huang, Dongwei Kang, Ye Tian, Dirk Daelemans, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2020	30
17	Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery ACS Medicinal Chemistry Letters ·Dongwei Kang, Zhao Wang, Heng Zhang, Gaochan Wu, Tong Zhao, Zhongxia Zhou, Zhipeng Huo, Boshi Huang, Da Feng, Xiao Ding, Jian Zhang, Xiaofang Zuo, Lanlan Jing, Wei Luo, Samuel Desta Guma, Dirk Daelemans, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2018	29
18	Discovery of piperidine-substituted thiazolo[5,4-d]pyrimidine derivatives as potent and orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitors Communications Chemistry ·Dongwei Kang, Tong Zhao, Zhao Wang, Da Feng, Heng Zhang, Boshi Huang, Gaochan Wu, Fenju Wei, Zhongxia Zhou, Lanlan Jing, Xiaofang Zuo, Ye Tian, Vasanthanathan Poongavanam, Jacob Kongsted, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2019	29
19	Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket European Journal of Medicinal Chemistry ·Jiapei Yang, Wen‐Ming Chen, Dongwei Kang, Xueyi Lu, Xiao Li, Zhaoqiang Liu, Boshi Huang, Dirk Daelemans, Christophe Pannecouque, Erik De Clercq, Peng Zhan, Xinyong Liu	2015	29
20	Structural optimization of pyridine-type DAPY derivatives to exploit the tolerant regions of the NNRTI binding pocket European Journal of Medicinal Chemistry ·Wen‐Ming Chen, Peng Zhan, Dirk Daelemans, Jiapei Yang, Boshi Huang, Erik De Clercq, Christophe Pannecouque, Xinyong Liu	2016	29

About Boshi Huang

Boshi Huang is a scholar working on Infectious Diseases, Virology, Molecular Biology, Organic Chemistry and Epidemiology, having authored 70 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (37 papers), HIV Research and Treatment (30 papers), Click Chemistry and Applications (18 papers), Pneumocystis jirovecii pneumonia detection and treatment (13 papers), Receptor Mechanisms and Signaling (9 papers), Neuropeptides and Animal Physiology (8 papers), Hemoglobinopathies and Related Disorders (5 papers) and Biochemical and Molecular Research (5 papers). The work is most often cited by research in Virology (549 citations), Infectious Diseases (703 citations), Organic Chemistry (664 citations), Epidemiology (396 citations) and Molecular Biology (621 citations). Boshi Huang has collaborated with scholars based in China, Belgium and United States. Frequent co-authors include Xinyong Liu, Peng Zhan, Dongwei Kang, Erik De Clercq, Christophe Pannecouque, Yan Zhang, Dirk Daelemans, Xueshun Wang, Zhongxia Zhou and T.B. Ng. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Drug Discovery Today, Expert Opinion on Therapeutic Patents and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Boshi Huang

Impact in

Papers in i

In The Last Decade

Boshi Huang

Peers

Countries citing papers authored by Boshi Huang

Fields of papers citing papers by Boshi Huang

All Works

About Boshi Huang

Explore authors with similar magnitude of impact

Papers in